Related Experiment Videos

Reactive metabolites as a cause of hepatotoxicity

International Journal of Clinical Pharmacology Research
|January 1, 1983
PubMed

Insights

Many drugs cause liver damage by forming toxic metabolites. This process, known as drug-induced hepatotoxicity, can lead to severe liver injury, but protective mechanisms exist.

Area of Science:

  • Biochemistry
  • Toxicology
  • Pharmacology

Background:

  • Many compounds, including drugs, can cause liver damage (hepatotoxicity).
  • This damage occurs via biotransformation into reactive cytotoxic metabolites.
  • These metabolites can covalently bind to liver macromolecules, leading to cell injury.

Purpose of the Study:

  • To explain the mechanisms of drug-induced hepatotoxicity.
  • To highlight the role of metabolic activation and inactivation in liver injury.
  • To discuss protective factors and modulators of toxicity.

Main Methods:

  • Review of biochemical pathways involved in drug metabolism.
  • Analysis of the interaction between reactive metabolites and cellular components.
  • Examination of the role of glutathione in detoxification.

Main Results:

  • Hepatotoxicity results from an imbalance between metabolic activation and inactivation.
  • Reactive metabolites bind to hepatic macromolecules, causing cell damage.
  • Reduced glutathione acts as a protective agent by trapping electrophilic metabolites.

Conclusions:

  • Drug-induced liver injury is a significant clinical concern.
  • Understanding metabolic pathways is crucial for predicting and preventing hepatotoxicity.
  • Modulating enzyme activity and enhancing protective mechanisms may mitigate liver damage.

Related Concept Videos